In the present study, reduced expression of Bcl-2 and Bcl-xL in PCA treated HT-29 cells may have resulted in the activation of activator proteins (Bid, Bak) and induction of HT-29 cell apoptosis. The gene discussed is BCL2; the disease is posterior cortical atrophy.